Safety and antibody response to inactivated COVID-19 vaccine in patients with chronic hepatitis B virus infection.

Taiyu HeYingzhi ZhouPan XuNing LingMin ChenTianquan HuangBiqiong ZhangZiqiao YangLing AoHu LiZhiwei ChenDazhi ZhangXiaofeng ShiYu LeiZhiyi WangWeiqun ZengPeng HuYinghua LanZhi ZhouJuan KangYing HuangTongdong ShiQingbo PanQian ZhuXiping RanYingzhi ZhangRui SongDejuan XiangShuang XiaoGaoli ZhangWei ShenMingli PengDachuan CaiHong Ren

Published in: Liver international : official journal of the International Association for the Study of the Liver (2022)

Inactivated COVID-19 vaccines were well tolerated, and induced effective antibody response against SARS-CoV-2 in CHB patients.

Keyphrases

sars cov
coronavirus disease
end stage renal disease
respiratory syndrome coronavirus
ejection fraction
newly diagnosed
chronic kidney disease
peritoneal dialysis
high glucose
diabetic rats
endothelial cells